NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/24/2024
Back to search
Official data from USPTO
SANGUINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
12/24/2024
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
07/21/2023
Registration date
12/24/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/24/2024
Last transaction
12/24/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2010-00-00
First use in commerce
2010-00-00
Drawing code
3
Owner type
03
Owner location
Woburn, MA
Examiner
SHANOSKI, JOANNA MARIE
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "SANGUINE" wherein the dot over the letter "i" is a droplet.
Holders and representatives
Holders
Sanguine Biosciences, Inc.
Representatives
Elizabeth Oliner OLINER LAW
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research laboratory analysis of biospecimens for cell analysis assayscell countimmunophenotypingHLA typing for use in infectious disease research; Research laboratory services providing biospecimen analysiscell analysis assayscell countimmunophenotypingHLA typing for use in infectious disease research; Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research in the fields of autoimmune diseasesgenetic disordersneurological disordersoncologyinfectious diseasesimmunology related to biomarker discovery and validationdrug discovery and developmentdiagnostics developmenttranslational applications; Providing an online searchable database in the field of autoimmune diseasesgenetic disordersneurological disordersoncologyinfectious diseasesimmunology and health for scientific research purposes; Providing an online searchable database in the field of biospecimen and data collection for scientific research purposes; Providing information about medical research in the field of autoimmune diseasesgenetic disordersneurological disordersoncologyinfectious diseasesimmunology for purposes including biomarker discovery and validationdrug discovery and developmentdiagnostics developmentother translational applications; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Scientific laboratory services; Scientific research for medical purposes in the field of autoimmune diseasesgenetic disordersneurological disordersoncologyinfectious diseasesimmunologybiomarker discovery and validationdrug discovery and developmentdiagnostics developmenttranslational applications; Scientific research in the field of autoimmune diseasesgenetic disordersneurological disordersoncologyinfectious diseasesoncology and health research; Providing biospecimen collection and data collection for scientific research purposes in the field of autoimmune diseasesgenetic disordersneurological disordersoncologyinfectious diseasesimmunologybiomarker discovery and validationdrug discovery and developmentdiagnostics developmenttranslational applications
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/24/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/05/2024
PUBO
PUBLISHED FOR OPPOSITION
11/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/16/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
09/03/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/03/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
09/03/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/29/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/29/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/29/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/02/2024
GNFR
FINAL REFUSAL E-MAILED
07/02/2024
CNFR
FINAL REFUSAL WRITTEN
07/02/2024
RTTP
RESTORE TO TEAS PLUS
07/02/2024
RFTP
REMOVED FROM TEAS PLUS
07/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/25/2024
GNRT
NON-FINAL ACTION E-MAILED
03/25/2024
CNRT
NON-FINAL ACTION WRITTEN
03/25/2024
DOCK
ASSIGNED TO EXAMINER
03/25/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/22/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/21/2023
NWAP
NEW APPLICATION ENTERED
07/25/2023
Continuous trademark protection
Get notified about every new filing that threatens SANGUINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.